> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Creutzfeldt-Jakob Disease Risk Reductions
- URL: https://www.fdaweb.com/guide-on-creutzfeldt-jakob-disease-risk-reductions/
- Published: 2020-01-31T12:00:00.000Z
- Updated: 2026-09-14T16:01:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145982

*Federal Register* notice: FDA makes available a draft guidance entitled “Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt Jakob Disease by Blood and Blood Components.’’ The recommendations apply to blood and blood component collection intended for transfusion or for use in further manufacturing. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-01-31/pdf/2020-01815.pdf?ref=fdaweb.com).